Itacitinib
Itacitinib (INCB039110) is an orally active and selective inhibitor of JAK1 with an IC50 of 2 nM for human JAK1. Itacitinib shows >20-fold selectivity for JAK1 over JAK2 and >100-fold over JAK3 and TYK2; Itacitinib is used in the research of myelofibrosis[1][2].
Product Specifications
CAS Number
1334298-90-6
Product Name Alternative
INCB039110
UNSPSC
12352005
Hazard Statement
H301, H311, H331
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Itacitinib.html
Purity
99.97
Solubility
DMSO : ≥ 30 mg/mL
Smiles
N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(C5CCN(C(C6=C(F)C(C(F)(F)F)=NC=C6)=O)CC5)C1
Molecular Formula
C26H23F4N9O
Molecular Weight
553.51
Precautions
H301, H311, H331
References & Citations
[1]Mascarenhas JO, et al. Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis. Haematologica. 2017 Feb;102 (2) :327-335.|[2]Alain Lescoat, et al. Combined Anti-Fibrotic and Anti-Inflammatory Properties of JAK-inhibitors on Macrophages in Vitro and in Vivo: Perspectives for Scleroderma-Associated Interstitial Lung Disease. Biochem Pharmacol. 2020 Jun 17;114103.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
JAK1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-346392A 5 g
3-Amino-N- (3-bromo-4-ethoxy-phenyl) -benzenesulfonamide
Sign In for Pricing
View Details 
EH25097 96 Tests
Human BRCA1 (Breast Cancer Susceptibility Protein 1) ELISA Kit
Sign In for Pricing
View Details TL703450V 500 µL Each
Foxk1 Rat shRNA Lentiviral Particle (Locus ID 304298)
Sign In for Pricing
View Details